🕵️ Cellectar Biosciences, Inc. ($CLRB)
SEC insider & ownership activity, last 12 months · CIK 1279704 · every row links its SEC filing
Over the last 12 months insiders sold $732 against $51K of open-market buying. James V. Caruso bought $25K in discretionary trades (May). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $51K (4 lots) · 1 seller, $732 (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| James V. Caruso | 2 | $25K | 0 | – | May 7, 2026 |
| Longcor Jarrod | 2 | $25K | 0 | – | May 7, 2026 |
| Neis John | 0 | – | 1 | $732 | Dec 12, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 10.0% | 13G | Jun 5, 2026 | filing ↗ | |
| Stonepine Capital Management, LLC | 9.9% | 13G | May 11, 2026 | filing ↗ | |
| Stonepine Capital, L.P. | 9.9% | 13G | May 11, 2026 | filing ↗ | |
| Stonepine GP, LLC | 9.9% | 13G | May 11, 2026 | filing ↗ | |
| Jon M. Plexico | 9.9% | 13G | May 11, 2026 | filing ↗ | |
| Rosalind Advisors, Inc. | 5.5% | 13G | Feb 10, 2026 | filing ↗ | |
| Salamon Steven A J | 5.5% | 13G | Feb 10, 2026 | filing ↗ | |
| Aharon Gil | 5.5% | 13G | Feb 10, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 7, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jul 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 17, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Material agreement (1.01) | May 4, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 4, 2026 | filing ↗ |
| Other events (8.01) | May 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 4, 2026 | filing ↗ |
| Earnings (2.02) | Mar 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 4, 2026 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 7, 2025 | filing ↗ |
| Earnings (2.02) | Oct 7, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 7, 2025 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Oct 7, 2025 | filing ↗ |
| Other events (8.01) | Oct 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 7, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 6, 2025 | filing ↗ |
| Other events (8.01) | Oct 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 6, 2025 | filing ↗ |
| Earnings (2.02) | Aug 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 14, 2025 | filing ↗ |